|
1）Mozaffarian D, Lemaitre RN, King LB, et al. Plasma phospholibid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: the cardiovascular health study. Ann Intern Med. 2013; 158: 515-25
|
|
|
|
2）Bosch J, Gerstein HC, Dagenais GR, et al. ORIGIN Trial Investigators. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med. 2012; 367: 309-18
|
|
|
|
|
|
3）Rizos EC, Ntzani EE, Kostapanos MS, et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events. A systematic review and meta-analysis. JAMA. 2012; 308: 1024-33
|
|
|
|
|
|
4）Lonn EM, Bosch J, Diaz R, et al. Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: The glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE). Diabetes Care. 2013; 36: 2466-74
|
|
|
|
|
|
5）The risk and prevention study collaborative group. N-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med. 2013; 368: 1800-8
|
|
|
|
|
|
6）Kondo K, Morino K, Nishio Y, et al. Effects of a fish-based diet on the serum adiponectin concentration in young, non-obese, healthy Japanese subjects. J Atheroscler Thromb. 2010; 17: 628-37
|
|
|
|
|
7）Ishikado A, Morino K, Nishio Y, et al. 4-hydroxy hexenal derived from docosahexaenoic acid protects endothelial cells via Nrf2 activation. PLoS One. 2013; 8: e69415
|
|
|
|
|
|
8）Ishikado A, Nishio Y, Morino K, et al. Low concentration of 4-hydroxy hexenal increases heme oxgenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells. Biochem Biophys Res Commun. 2010; 402: 99-104
|
|
|
|
|
|
9）Kusunoki C, Yang L, Yoshizaki T, et al. Omega-3 polyunsaturated fatty acid has an anti-oxidant effects via the Nrf-2/HO-1 pathway in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2013; 430: 225-30
|
|
|
|
|
|
10）Gao LG, Cao J, Mao QX, et al. Influence of omega-3 polyunsaturated fatty acid-supplementation on platelet aggregation in humans: A meta-analysis of randomized controlled trials. Atherosclerosis. 2013; 226: 328-34
|
|
|
|
|
|
11）McDonald MD, O'Kane F, McConville M, et al. Platelet redox balance in diabetic patients with hypertension improved by n-3 fatty acids. Diabetes Care. 2013; 36: 998-1005
|
|
|
|
|
|
12）Shinozaki K, Kashiwagi A, Nishio Y, et al. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta. Diabetes. 1999; 48: 2437-45
|
|
|
|
|